|
1
|
Koutsilieris M: Osteoblastic metastasis in
advanced prostate cancer. Anticancer Res. 13:443–449.
1993.PubMed/NCBI
|
|
2
|
Chambers AF, Groom AC and MacDonald IC:
Dissemination and growth of cancer cells in metastatic sites. Nat
Rev Cancer. 2:563–572. 2002. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Valastyan S and Weinberg RA: Tumor
metastasis: Molecular insights and evolving paradigms. Cell.
147:275–292. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: The next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bagnyukova TV, Pogribny IP and Chekhun VF:
MicroRNAs in normal and cancer cells: A new class of gene
expression regulators. Exp Oncol. 28:263–269. 2006.PubMed/NCBI
|
|
6
|
Iorio MV and Croce CM: MicroRNAs in
cancer: Small molecules with a huge impact. J Clin Oncol.
27:5848–5856. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lu J, Getz G, Miska EA, Alvarez-Saavedra
E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA,
et al: MicroRNA expression profiles classify human cancers. Nature.
435:834–838. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Volinia S, Calin GA, Liu CG, Ambs S,
Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, et
al: A microRNA expression signature of human solid tumors defines
cancer gene targets. Proc Natl Acad Sci USA. 103:2257–2261. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nicoloso MS, Spizzo R, Shimizu M, Rossi S
and Calin GA: MicroRNAs-the micro steering wheel of tumour
metastases. Nat Rev Cancer. 9:293–302. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hurst DR, Edmonds MD and Welch DR:
Metastamir: The field of metastasis-regulatory microRNA is
spreading. Cancer Res. 69:7495–7498. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jerónimo C, Bastian PJ, Bjartell A,
Carbone GM, Catto JW, Clark SJ, Henrique R, Nelson WG and Shariat
SF: Epigenetics in prostate cancer: Biologic and clinical
relevance. Eur Urol. 60:753–766. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Porkka KP, Pfeiffer MJ, Waltering KK,
Vessella RL, Tammela TL and Visakorpi T: MicroRNA expression
profiling in prostate cancer. Cancer Res. 67:6130–6135. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shen MM and Abate-Shen C: Molecular
genetics of prostate cancer: New prospects for old challenges.
Genes Dev. 24:1967–2000. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Coppola V, De Maria R and Bonci D:
MicroRNAs and prostate cancer. Endocr Relat Cancer. 17:F1–F17.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Chiang Y, Song Y, Wang Z, Liu Z, Gao P,
Liang J, Zhu J, Xing C and Xu H: microRNA-192, −194 and −215 are
frequently downregulated in colorectal cancer. Exp Ther Med.
3:560–566. 2012.PubMed/NCBI
|
|
17
|
Senanayake U, Das S, Vesely P, Alzoughbi
W, Fröhlich LF, Chowdhury P, Leuschner I, Hoefler G and Guertl B:
miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated
and their common target ACVR2B is strongly expressed in renal
childhood neoplasms. Carcinogenesis. 33:1014–1021. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Meng Z, Fu X, Chen X, Zeng S, Tian Y, Jove
R, Xu R and Huang W: miR-194 is a marker of hepatic epithelial
cells and suppresses metastasis of liver cancer cells in mice.
Hepatology. 52:2148–2157. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhai H, Karaayvaz M, Dong P, Sakuragi N
and Ju J: Prognostic significance of miR-194 in endometrial cancer.
Biomark Res. 1:12013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Song Y, Zhao F, Wang Z, Liu Z, Chiang Y,
Xu Y, Gao P and Xu H: Inverse association between miR-194
expression and tumor invasion in gastric cancer. Ann Surg Oncol.
19:(Suppl 3). S509–S517. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang B, Shen ZL, Gao ZD, Zhao G, Wang CY,
Yang Y, Zhang JZ, Yan YC, Shen C, Jiang KW, et al: MiR-194,
commonly repressed in colorectal cancer, suppresses tumor growth by
regulating the MAP4K4/c-Jun/MDM2 signaling pathway. Cell Cycle.
14:1046–1058. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Dong P, Kaneuchi M, Watari H, Hamada J,
Sudo S, Ju J and Sakuragi N: MicroRNA-194 inhibits epithelial to
mesenchymal transition of endometrial cancer cells by targeting
oncogene BMI-1. Mol Cancer. 10:992011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Gocke CD, Osmani SA and Miller BA: The
human homologue of the Aspergillus nuclear migration gene nudC is
preferentially expressed in dividing cells and ciliated epithelia.
Histochem Cell Biol. 114:293–301. 2000.PubMed/NCBI
|
|
24
|
Zhang MY, Huang NN, Clawson GA, Osmani SA,
Pan W, Xin P, Razzaque MS and Miller BA: Involvement of the fungal
nuclear migration gene nudC human homolog in cell proliferation and
mitotic spindle formation. Exp Cell Res. 273:73–84. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Morris SM, Albrecht U, Reiner O, Eichele G
and Yu-Lee LY: The lissencephaly gene product Lis1, a protein
involved in neuronal migration, interacts with a nuclear movement
protein, NudC. Curr Biol. 8:603–606. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Aumais JP, Tunstead JR, McNeil RS, Schaar
BT, McConnell SK, Lin SH, Clark GD and Yu-Lee LY: NudC associates
with Lis1 and the dynein motor at the leading pole of neurons. J
Neurosci. 21:RC1872001.PubMed/NCBI
|
|
27
|
Aumais JP, Williams SN, Luo W, Nishino M,
Caldwell KA, Caldwell GA, Lin SH and Yu-Lee LY: Role for NudC, a
dynein-associated nuclear movement protein, in mitosis and
cytokinesis. J Cell Sci. 116:1991–2003. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou T, Aumais JP, Liu X, Yu-Lee LY and
Erikson RL: A role for Plk1 phosphorylation of NudC in cytokinesis.
Dev Cell. 5:127–138. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miller BA, Zhang MY, Gocke CD, De Souza C,
Osmani AH, Lynch C, Davies J, Bell L and Osmani SA: A homolog of
the fungal nuclear migration gene nudC is involved in normal and
malignant human hematopoiesis. Exp Hematol. 27:742–750. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Gocke CD, Reaman GH, Stine C, Zhang MY,
Osmani SA and Miller BA: The nuclear migration gene NudC and human
hematopoiesis. Leuk Lymphoma. 39:447–454. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Hartmann TB, Mattern E, Wiedemann N, van
Doorn R, Willemze R, Niikura T, Hildenbrand R, Schadendorf D and
Eichmüller SB: Identification of selectively expressed genes and
antigens in CTCL. Exp Dermatol. 17:324–334. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Suzuki SO, McKenney RJ, Mawatari SY,
Mizuguchi M, Mikami A, Iwaki T, Goldman JE, Canoll P and Vallee RB:
Expression patterns of LIS1, dynein and their interaction partners
dynactin, NudE, NudEL and NudC in human gliomas suggest roles in
invasion and proliferation. Acta Neuropathol. 113:591–599. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Hatakeyama H, Kondo T, Fujii K, Nakanishi
Y, Kato H, Fukuda S and Hirohashi S: Protein clusters associated
with carcinogenesis, histological differentiation and nodal
metastasis in esophageal cancer. Proteomics. 6:6300–6316. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Elbashir SM, Harborth J, Lendeckel W,
Yalcin A, Weber K and Tuschl T: Duplexes of 21-nucleotide RNAs
mediate RNA interference in cultured mammalian cells. Nature.
411:494–498. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Lin SH, Nishino M, Luo W, Aumais JP,
Galfione M, Kuang J and Yu-Lee LY: Inhibition of prostate tumor
growth by overexpression of NudC, a microtubule motor-associated
protein. Oncogene. 23:2499–2506. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2−ΔΔCT Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Lewis BP, Burge CB and Bartel DP:
Conserved seed pairing, often flanked by adenosines, indicates that
thousands of human genes are microRNA targets. Cell. 120:15–20.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Lewis BP, Shih IH, Jones-Rhoades MW,
Bartel DP and Burge CB: Prediction of mammalian microRNA targets.
Cell. 115:787–798. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Betel D, Koppal A, Agius P, Sander C and
Leslie C: Comprehensive modeling of microRNA targets predicts
functional non-conserved and non-canonical sites. Genome Biol.
11:R902010. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
John B, Enright AJ, Aravin A, Tuschl T,
Sander C and Marks DS: Human MicroRNA targets. PLoS Biol.
2:e3632004. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Enright AJ, John B, Gaul U, Tuschl T,
Sander C and Marks DS: MicroRNA targets in Drosophila. Genome Biol.
5:R12003. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Faircloth LM, Churchill PF, Caldwell GA
and Caldwell KA: The microtubule-associated protein, NUD-1,
exhibits chaperone activity in vitro. Cell Stress Chaperones.
14:95–103. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Xiang X, Osmani AH, Osmani SA, Xin M and
Morris NR: NudF, a nuclear migration gene in Aspergillus nidulans,
is similar to the human LIS-1 gene required for neuronal migration.
Mol Biol Cell. 6:297–310. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Pan RM, Yang Y, Wei MX, Yu XB, Ge YC and
Xu P: A microtubule associated protein (hNUDC) binds to the
extracellular domain of thrombopoietin receptor (Mpl). J Cell
Biochem. 96:741–750. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wei MX, Yang Y, Ge YC and Xu P: Functional
characterization of hNUDC as a novel accumulator that specifically
acts on in vitro megakaryocytopoiesis and in vivo platelet
production. J Cell Biochem. 98:429–439. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Tang YS, Zhang YP and Xu P: hNUDC promotes
the cell proliferation and differentiation in a leukemic cell line
via activation of the thrombopoietin receptor (Mpl). Leukemia.
22:1018–1025. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Zhang C, Shu L, Kim H, Khor TO, Wu R, Li W
and Kong AN: Phenethyl isothiocyanate (PEITC) suppresses prostate
cancer cell invasion epigenetically through regulating
microRNA-194. Mol Nutr Food Res. 60:1427–1436. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Selth LA, Townley SL, Bert AG, Stricker
PD, Sutherland PD, Horvath LG, Goodall GJ, Butler LM and Tilley WD:
Circulating microRNAs predict biochemical recurrence in prostate
cancer patients. Br J Cancer. 109:641–650. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Sundaram P, Hultine S, Smith LM, Dews M,
Fox JL, Biyashev D, Schelter JM, Huang Q, Cleary MA, Volpert OV, et
al: p53-responsive miR-194 inhibits thrombospondin-1 and promotes
angiogenesis in colon cancers. Cancer Res. 71:7490–7501. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Chen X, Wang Y, Zang W, Du Y, Li M and
Zhao G: miR-194 targets RBX1 gene to modulate proliferation and
migration of gastric cancer cells. Tumour Biol. 36:2393–2401. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Xu J, Kang Y, Liao WM and Yu L: MiR-194
regulates chondrogenic differentiation of human adipose-derived
stem cells by targeting Sox5. PLoS One. 7:e318612012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Han K, Zhao T, Chen X, Bian N, Yang T, Ma
Q, Cai C, Fan Q, Zhou Y and Ma B: microRNA-194 suppresses
osteosarcoma cell proliferation and metastasis in vitro and in vivo
by targeting CDH2 and IGF1R. Int J Oncol. 45:1437–1449.
2014.PubMed/NCBI
|
